33874883 33926571 34122308 36768317 32523507 35063468 33629273 32581693 33453941 35052512 35812232 36085537 33323315 33526455 32430844 35101134 35065083 32415718 35614857 33219714 34528667 34657636 32499675 34871735 32617639 33297340 32736085 3366233 - Search Results

Year	Number of Results
2020	17
2021	18
2022	21
2023	2

1

Genotype-driven therapeutic developments in Parkinson's disease.

Prasuhn J, Brüggemann N. Prasuhn J, et al. Mol Med. 2021 Apr 19;27(1):42. doi: 10.1186/s10020-021-00281-8. Mol Med. 2021. PMID: 33874883 Free PMC article. Review.

2

Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson's disease.

Coccia E, Ahfeldt T. Coccia E, et al. Stem Cell Res Ther. 2021 Apr 29;12(1):253. doi: 10.1186/s13287-021-02326-5. Stem Cell Res Ther. 2021. PMID: 33926571 Free PMC article. Review.

3

The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?

MacMahon Copas AN, McComish SF, Fletcher JM, Caldwell MA. MacMahon Copas AN, et al. Front Neurol. 2021 May 26;12:666737. doi: 10.3389/fneur.2021.666737. eCollection 2021. Front Neurol. 2021. PMID: 34122308 Free PMC article. Review.

4

Glial Cultures Differentiated from iPSCs of Patients with PARK2-Associated Parkinson's Disease Demonstrate a Pro-Inflammatory Shift and Reduced Response to TNFα Stimulation.

Gerasimova T, Stepanenko E, Novosadova L, Arsenyeva E, Shimchenko D, Tarantul V, Grivennikov I, Nenasheva V, Novosadova E. Gerasimova T, et al. Int J Mol Sci. 2023 Jan 19;24(3):2000. doi: 10.3390/ijms24032000. Int J Mol Sci. 2023. PMID: 36768317 Free PMC article.

5

"LRRK2: Autophagy and Lysosomal Activity".

Madureira M, Connor-Robson N, Wade-Martins R. Madureira M, et al. Front Neurosci. 2020 May 25;14:498. doi: 10.3389/fnins.2020.00498. eCollection 2020. Front Neurosci. 2020. PMID: 32523507 Free PMC article. Review.

6

Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson's disease.

Francelle L, Mazzulli JR. Francelle L, et al. Brain Res. 2022 Apr 1;1780:147798. doi: 10.1016/j.brainres.2022.147798. Epub 2022 Jan 19. Brain Res. 2022. PMID: 35063468 Free PMC article. Review.

7

Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.

Streubel-Gallasch L, Giusti V, Sandre M, Tessari I, Plotegher N, Giusto E, Masato A, Iovino L, Battisti I, Arrigoni G, Shimshek D, Greggio E, Tremblay ME, Bubacco L, Erlandsson A, Civiero L. Streubel-Gallasch L, et al. Mol Neurobiol. 2021 Jul;58(7):3119-3140. doi: 10.1007/s12035-021-02327-8. Epub 2021 Feb 24. Mol Neurobiol. 2021. PMID: 33629273 Free PMC article.

8

LRRK2-Related Parkinson's Disease Due to Altered Endolysosomal Biology With Variable Lewy Body Pathology: A Hypothesis.

Rivero-Ríos P, Romo-Lozano M, Fasiczka R, Naaldijk Y, Hilfiker S. Rivero-Ríos P, et al. Front Neurosci. 2020 Jun 4;14:556. doi: 10.3389/fnins.2020.00556. eCollection 2020. Front Neurosci. 2020. PMID: 32581693 Free PMC article. Review.

9

Inflammation and Parkinson's disease pathogenesis: Mechanisms and therapeutic insight.

Forloni G, La Vitola P, Cerovic M, Balducci C. Forloni G, et al. Prog Mol Biol Transl Sci. 2021;177:175-202. doi: 10.1016/bs.pmbts.2020.11.001. Epub 2020 Dec 15. Prog Mol Biol Transl Sci. 2021. PMID: 33453941

10

The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention.

Boas SM, Joyce KL, Cowell RM. Boas SM, et al. Antioxidants (Basel). 2021 Dec 21;11(1):8. doi: 10.3390/antiox11010008. Antioxidants (Basel). 2021. PMID: 35052512 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results